8
Oct
2024

LOTTE Biologics

Exhibitor at CPHI Milan 2024 stand 5C73, Contract Manufacturing and Services
About Us

LOTTE BIOLOGICS, is a premier global CDMO dedicated to providing top-quality biopharmaceuticals. We have pursued swift global expansion following the acquisition of BMS' Syracuse site, a location with over 62 international regulatory approvals and a 40,000L production capacity. Our capabilities span from cell line development to biologics drug substance manufacturing, with an ADC conjugation facility planned. Future expansion includes three Mega Plants in Korea with a projected capacity exceeding +360,000L by 2030 with the first plant expected to be GMP-ready by 4Q 2026. 

  • KR
  • 2022
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 5C73, Contract Manufacturing and Services